The impact of cancer biology, lead time bias, and length bias in the debate about cancer screening tests.
Kay
B R
BR
Witte
D L
DL
D015982:Bias; D014408:Biomarkers, Tumor; D015331:Cohort Studies; D006801:Humans; D008403:Mass Screening; D009447:Neuroblastoma / Q000175:diagnosis* / Q000453:epidemiology; D010265:Paraproteinemias / Q000175:diagnosis* / Q000453:epidemiology